Background and Aims Assessment of disease activity is essential for developing and
determining appropriate therapy in patients with ulcerative colitis (UC). Validated clinical …

Simple Summary Patients with inflammatory bowel disease are at an increased risk of
developing colorectal cancer, and so are enrolled in a surveillance colonoscopy programme …

Background & Aims Studies are needed to determine the mechanisms of mucosal
dysregulation in patients with inflammatory bowel diseases (IBDs) and differences in …

Currently, the main targets of drug therapy for ulcerative colitis [UC] are endoscopic and
clinical remission. However, there is active discussion about the additional advantages of …

The potential of probiotics for treating ulcerative colitis (UC) has attracted increasing
attention. However, more studies are still needed to guide physicians on the proper …

Background & Aims Ustekinumab induces and maintains histologic improvement in patients
with ulcerative colitis (UC). The clinical relevance of this endpoint alone, and in combination …

Objective Histological remission is being increasingly acknowledged as a therapeutic
endpoint in patients with UC. The work hereafter described aimed to evaluate the …

The aim of this study was to fabricate novel self-supporting tacrolimus suppositories using
semisolid extrusion 3-dimensional printing (3DP) and to investigate their efficacy in an …

Background Beyond endoscopic remission, histological remission in ulcerative colitis (UC)
is predictive of clinical outcomes. Intestinal ultrasound (IUS) may offer a noninvasive …

Ulcerative colitis is a chronic inflammatory bowel disease that is characterized by a
relapsing and remitting course. Assessment of disease activity critically informs treatment …